Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimer Dis Assoc Disord

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    September 2018
  1. ARBOLEDA-BUSTOS CE, Ortega-Rojas J, Mahecha MF, Arboleda G, et al
    The p.R47H Variant of TREM2 Gene is Associated With Late-onset Alzheimer Disease in Colombian Population.
    Alzheimer Dis Assoc Disord. 2018 Sep 14. doi: 10.1097/WAD.0000000000000275.
    PubMed     Text format     Abstract available


  2. GAGLIARDI S, Davin A, Bini P, Sinforiani E, et al
    A Novel Nonsense Angiogenin Mutation is Associated With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2018 Sep 4. doi: 10.1097/WAD.0000000000000272.
    PubMed     Text format    


    August 2018
  3. WELLS JL, Pasternak SH
    Case Report of a 63-Year-Old Patient With Alzheimer Disease and a Novel Presenilin 2 Mutation.
    Alzheimer Dis Assoc Disord. 2018 Aug 16. doi: 10.1097/WAD.0000000000000269.
    PubMed     Text format    


  4. KNAPSKOG AB, Braekhus A, Engedal K
    The Effect of Changing the Amyloid beta42 Cut-off of Cerebrospinal Fluid Biomarkers on Alzheimer Disease Diagnosis in a Memory Clinic Population in Norway.
    Alzheimer Dis Assoc Disord. 2018 Aug 13. doi: 10.1097/WAD.0000000000000268.
    PubMed     Text format    


    July 2018
  5. JIA X, Shi L, Qian T, Li Y, et al
    Improved Gray Matter Atrophy Detection in Alzheimer Disease in Chinese Populations Using Chinese Brain Template.
    Alzheimer Dis Assoc Disord. 2018 Jul 17. doi: 10.1097/WAD.0000000000000264.
    PubMed     Text format     Abstract available


    June 2018
  6. BARBER JM, Bardach SH, Jicha GA
    Alzheimer Disease Clinical Trial Recruitment: Does Participation in a Brief Cognitive Screen at a Community Health Fair Promote Research Engagement?
    Alzheimer Dis Assoc Disord. 2018 Jun 25. doi: 10.1097/WAD.0000000000000263.
    PubMed     Text format     Abstract available


  7. STITES SD, Harkins K, Rubright JD, Karlawish J, et al
    Relationships Between Cognitive Complaints and Quality of Life in Older Adults With Mild Cognitive Impairment, Mild Alzheimer Disease Dementia, and Normal Cognition.
    Alzheimer Dis Assoc Disord. 2018 Jun 25. doi: 10.1097/WAD.0000000000000262.
    PubMed     Text format     Abstract available


    May 2018
  8. GROSSBERG GT, Alva G, Hendrix S, Ellison N, et al
    Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors.
    Alzheimer Dis Assoc Disord. 2018 May 16. doi: 10.1097/WAD.0000000000000261.
    PubMed     Text format     Abstract available


  9. BAHIA VS, Cecchini MA, Cassimiro L, Viana R, et al
    The Accuracy of INECO Frontal Screening in the Diagnosis of Executive Dysfunction in Frontotemporal Dementia and Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2018 May 4. doi: 10.1097/WAD.0000000000000255.
    PubMed     Text format     Abstract available


    April 2018
  10. PIERCE AL, Cox CG, Nguyen H, Hoang D, et al
    Participant Satisfaction With Learning Alzheimer Disease Clinical Trial Results.
    Alzheimer Dis Assoc Disord. 2018 Apr 20. doi: 10.1097/WAD.0000000000000258.
    PubMed     Text format    


    March 2018
  11. ALLISON S, Babulal GM, Stout SH, Barco PP, et al
    Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities.
    Alzheimer Dis Assoc Disord. 2018 Mar 23. doi: 10.1097/WAD.0000000000000257.
    PubMed     Text format     Abstract available


  12. BRADFIELD NI, Ellis KA, Savage G, Maruff P, et al
    Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.
    Alzheimer Dis Assoc Disord. 2018 Mar 20. doi: 10.1097/WAD.0000000000000252.
    PubMed     Text format     Abstract available


  13. LADEIRA F, Cacao G, Correia AP, Pinto PS, et al
    When Decrease Abeta1-42 in CSF May Not Mean Alzheimer's Disease: Insights From Two Case Reports With Early Onset Dementia.
    Alzheimer Dis Assoc Disord. 2018 Mar 9. doi: 10.1097/WAD.0000000000000248.
    PubMed     Text format    


    January 2018
  14. GABEL M, Gooblar J, Roe CM, Selsor NJ, et al
    Political Ideology, Confidence in Science, and Participation in Alzheimer Disease Research Studies.
    Alzheimer Dis Assoc Disord. 2018 Jan 18. doi: 10.1097/WAD.0000000000000244.
    PubMed     Text format     Abstract available


  15. MILAN-TOMAS A, Shapiro CM
    Circadian Rhythms Disturbances in Alzheimer Disease: Current Concepts, Diagnosis, and Management.
    Alzheimer Dis Assoc Disord. 2018 Jan 18. doi: 10.1097/WAD.0000000000000243.
    PubMed     Text format     Abstract available


    December 2017
  16. SOUSA MFB, Santos RL, Simoes P, Conde-Sala JL, et al
    Discrepancies Between Alzheimer's Disease Patients' and Caregivers' Ratings About Patients' Quality of Life: A 1-year Observation Study in Brazil.
    Alzheimer Dis Assoc Disord. 2017 Dec 27. doi: 10.1097/WAD.0000000000000232.
    PubMed     Text format     Abstract available


  17. WEINTRAUB S, Besser L, Dodge HH, Teylan M, et al
    Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS).
    Alzheimer Dis Assoc Disord. 2017 Dec 13. doi: 10.1097/WAD.0000000000000223.
    PubMed     Text format     Abstract available


    November 2017
  18. TENSIL M, Hessler JB, Gutsmiedl M, Riedl L, et al
    Sex Differences in Neuropsychological Test Performance in Alzheimer's Disease and the Influence of the ApoE Genotype.
    Alzheimer Dis Assoc Disord. 2017 Nov 17. doi: 10.1097/WAD.0000000000000229.
    PubMed     Text format     Abstract available


    October 2017
  19. LACERDA IB, Santos RL, Neto JPS, Dourado MCN, et al
    Factors Related to Different Objects of Awareness in Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017;31:335-342.
    PubMed     Text format     Abstract available


    September 2017
  20. MOULDER KL, Besser LM, Beekly D, Blennow K, et al
    Factors Influencing Successful Lumbar Puncture in Alzheimer Research.
    Alzheimer Dis Assoc Disord. 2017 Sep 7. doi: 10.1097/WAD.0000000000000209.
    PubMed     Text format     Abstract available


    August 2017
  21. PANEGYRES PK, Goh J, McCarthy M, Campbell AI, et al
    The Nature and Natural History of Posterior Cortical Atrophy Syndrome: A Variant of Early-onset Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 Aug 8. doi: 10.1097/WAD.0000000000000207.
    PubMed     Text format     Abstract available


  22. ZADORI D, Fuvesi J, Timar E, Horvath E, et al
    The Report of p.Val717Phe Mutation in the APP Gene in a Hungarian Family With Alzheimer Disease: A Phenomenological Study.
    Alzheimer Dis Assoc Disord. 2017 Aug 8. doi: 10.1097/WAD.0000000000000206.
    PubMed     Text format    


    June 2017
  23. STONNINGTON CM, Harel B, Locke DEC, Hentz JG, et al
    Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 Jun 2. doi: 10.1097/WAD.0000000000000200.
    PubMed     Text format     Abstract available


    May 2017
  24. AZAR M, Zhu C, DeFeis B, Gu Y, et al
    Increased Reporting Accuracy of Alzheimer Disease Symptoms in Caribbean Hispanic Informants.
    Alzheimer Dis Assoc Disord. 2017 May 26. doi: 10.1097/WAD.0000000000000199.
    PubMed     Text format     Abstract available


  25. MICHAUD TL, High R, Charlton ME, Murman DL, et al
    Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 May 8. doi: 10.1097/WAD.0000000000000198.
    PubMed     Text format     Abstract available


    April 2017
  26. DAY GS, Gordon BA, Jackson K, Christensen JJ, et al
    Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia.
    Alzheimer Dis Assoc Disord. 2017 Apr 7. doi: 10.1097/WAD.0000000000000196.
    PubMed     Text format     Abstract available


  27. KOENIG AM, Mechanic-Hamilton D, Xie SX, Combs MF, et al
    Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study.
    Alzheimer Dis Assoc Disord. 2017;31:107-113.
    PubMed     Text format     Abstract available


    March 2017
  28. MORENO DJ, Pino S, Rios A, Lopera F, et al
    Genetic Ancestry and Susceptibility to Late-Onset Alzheimer's Disease (LOAD) in the Admixed Colombian Population.
    Alzheimer Dis Assoc Disord. 2017 Mar 31. doi: 10.1097/WAD.0000000000000195.
    PubMed     Text format     Abstract available


  29. OPOKU ST, Apenteng BA, Lin G
    Temporal Trends and Rural-Urban Differences in Hospital Length of Stay for Alzheimer Disease and Related Disorders.
    Alzheimer Dis Assoc Disord. 2017 Mar 14. doi: 10.1097/WAD.0000000000000183.
    PubMed     Text format     Abstract available


    January 2017
  30. VELAYOS-BAEZA A, Danek A
    Chorein Deficiency and Alzheimer Disease: An Intriguing, Yet Premature Speculation.
    Alzheimer Dis Assoc Disord. 2017 Jan 24. doi: 10.1097/WAD.0000000000000186.
    PubMed     Text format    


  31. LAZARCZYK MJ, Haller S, Savioz A, Gimelli S, et al
    Heterozygous Deletion of Chorein Exons 70-73 and GNA14 Exons 3-7 in a Brazilian Patient Presenting With Probable Tau-Negative Early-Onset Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2017 Jan 10. doi: 10.1097/WAD.0000000000000185.
    PubMed     Text format    


    December 2016
  32. PARK SA, Chae WS, Kim HJ, Shin HS, et al
    Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea.
    Alzheimer Dis Assoc Disord. 2016 Dec 23. doi: 10.1097/WAD.0000000000000184.
    PubMed     Text format     Abstract available


  33. RITTER AR, Leger GC, Miller JB, Banks SJ, et al
    Neuropsychological Testing in Pathologically Verified Alzheimer Disease and Frontotemporal Dementia: How Well Do the Uniform Data Set Measures Differentiate Between Diseases?
    Alzheimer Dis Assoc Disord. 2016 Dec 21. doi: 10.1097/WAD.0000000000000181.
    PubMed     Text format     Abstract available


    November 2016
  34. TREBBASTONI A, Marcelli M, Mallone F, D'Antonio F, et al
    Attenuation of Choroidal Thickness in Patients With Alzheimer Disease: Evidence From an Italian Prospective Study.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  35. SUGIMOTO T, Ono R, Murata S, Saji N, et al
    Sarcopenia is Associated With Impairment of Activities of Daily Living in Japanese Patients With Early-Stage Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format    


  36. MONSELL SE, Mock C, Fardo DW, Bertelsen S, et al
    Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  37. DEVANAND DP, Pelton GH, D'Antonio K, Strickler JG, et al
    Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format    


  38. VERHULSDONK S, Lange-Asschenfeldt C, Hoft B, Schwender H, et al
    Repressive Coping Does Not Contribute to Anosognosia in First-Diagnosis Patients With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  39. DE LUCIA N, Grossi D, Trojano L
    Closing-in is Related to Daily Living Functioning in Patients With Mild-to-Moderate Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format    


    October 2016
  40. PRUZIN JJ, Schneider JA, Capuano AW, Leurgans SE, et al
    Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


  41. ZUCCHELLA C, Bartolo M, Bernini S, Picascia M, et al
    Modeling Alzheimer's Disease Through Functional Independence and Participation.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


    September 2016
  42. LAGARDE J, Sarazin M, Chauvire V, Stankoff B, et al
    Cholinergic Changes in Aging and Alzheimer Disease: An [18F]-F-A-85380 Exploratory PET Study.
    Alzheimer Dis Assoc Disord. 2016.
    PubMed     Text format     Abstract available


    January 2016
  43. GERSTENECKER A, Triebel KL, Martin R, Snyder S, et al
    Both Financial and Cognitive Decline Predict Clinical Progression in MCI.
    Alzheimer Dis Assoc Disord. 2016;30:27-34.
    PubMed     Text format     Abstract available


  44. WALTER S, Marden JR, Kubzansky LD, Mayeda ER, et al
    Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study.
    Alzheimer Dis Assoc Disord. 2016;30:15-20.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: